542
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Economic impact of managing invasive mold disease with isavuconazole compared with liposomal amphotericin B followed by posaconazole in Spain

, , , , , , & show all
Received 04 Dec 2023, Accepted 29 Feb 2024, Published online: 18 Mar 2024

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.